Summary
21.94 0.73(3.44%)09/13/2024
Phibro Animal Health Corp. (PAHC)
Phibro Animal Health Corp. (PAHC)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 3.64 | 12.92 | 22.57 | 23.33 | 72.82 | 69.29 | 9.58 | 48.38 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 21.94 | |
| Open | 21.50 | |
| High | 22.06 | |
| Low | 21.06 | |
| Volume | 142,872 | |
| Change | 0.77 | |
| Change % | 3.64 | |
| Avg Volume (20 Days) | 157,627 | |
| Volume/Avg Volume (20 Days) Ratio | 0.91 | |
| 52 Week Range | 9.40 - 22.31 | |
| Price vs 52 Week High | -1.66% | |
| Price vs 52 Week Low | 133.40% | |
| Range | 2.05 | |
| Gap Up/Down | 0.10 | |
Fundamentals | ||
| Market Capitalization (Mln) | 891 | |
| EBIDTA | 93,794,000 | |
| PE Ratio | 47.4324 | |
| PEG Ratio | 1.6618 | |
| WallStreet Target Price | 10.75 | |
| Book Value | 6.6680 | |
| Earnings Per Share | 0.3700 | |
| EPS Estimate Current Quarter | 0.2900 | |
| EPS Estimate Next Quarter | 0.3500 | |
| EPS Estimate Current Year | 1.1000 | |
| EPS Estimate Next Year | 1.2300 | |
| Diluted EPS (TTM) | 0.3700 | |
| Revenues | ||
| Profit Marging | 0.0132 | |
| Operating Marging (TTM) | 0.0784 | |
| Return on asset (TTM) | 0.0384 | |
| Return on equity (TTM) | 0.0485 | |
| Revenue TTM | 999,564,032 | |
| Revenue per share TTM | 24.6780 | |
| Quarterly Revenue Growth (YOY) | 0.0710 | |
| Quarterly Earnings Growth (YOY) | -0.1630 | |
| Gross Profit (TTM) | 298,237,000 | |
| Dividends | ||
| Dividend Share | 0.4800 | |
| Dividend Yield | 0.0274 | |
| Valuations | ||
| Trailing PE | 47.4324 | |
| Forward PE | 10.5708 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.9608 | |
| Revenue Enterprise Value | 0.9690 | |
| EBITDA Enterprise Value | 11.3741 | |
| Shares | ||
| Shares Outstanding | 20,337,600 | |
| Shares Float | 20,211,300 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.05 | |
| Insider (%) | 0.63 | |
| Institutions (%) | 101.02 | |
09/13 12:06 EST - zacks.com
PAHC Stock Gains From Innovation, Market Expansion Goal
Phibro Animal Health's nutritional product offerings, such as OmniGen-AF and Animate, are being increasingly used in the global dairy industry.
PAHC Stock Gains From Innovation, Market Expansion Goal
Phibro Animal Health's nutritional product offerings, such as OmniGen-AF and Animate, are being increasingly used in the global dairy industry.
09/09 10:46 EST - zacks.com
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
09/06 13:00 EST - zacks.com
Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) is a Great Choice
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) is a Great Choice
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
09/02 12:47 EST - zacks.com
PAHC vs. ABT: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
PAHC vs. ABT: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
09/02 10:51 EST - zacks.com
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
09/02 10:15 EST - zacks.com
Phibro (PAHC) International Revenue Performance Explored
Examine the evolution of Phibro's (PAHC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Phibro (PAHC) International Revenue Performance Explored
Examine the evolution of Phibro's (PAHC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
08/29 18:08 EST - seekingalpha.com
Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2024 Earnings Call Transcript August 29, 2024 9:00 AM ET Company Participants Glenn David - CFO Jack Bendheim - Chairman, President, and CEO Daniel Bendheim - Director and EVP of Corporate Strategy Conference Call Participants Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Good morning. My name is Julianne and I will be your conference operator today.
Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2024 Earnings Call Transcript August 29, 2024 9:00 AM ET Company Participants Glenn David - CFO Jack Bendheim - Chairman, President, and CEO Daniel Bendheim - Director and EVP of Corporate Strategy Conference Call Participants Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Good morning. My name is Julianne and I will be your conference operator today.
08/29 16:00 EST - businesswire.com
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David along with Chief Operating Officer, Larry Miller will address financial analysts and investors on Thursday, September 5, 2024, at 1:05 PM ET at the New York Marriott Marquis. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website.
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David along with Chief Operating Officer, Larry Miller will address financial analysts and investors on Thursday, September 5, 2024, at 1:05 PM ET at the New York Marriott Marquis. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website.
08/29 10:41 EST - zacks.com
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
08/29 09:46 EST - zacks.com
Phibro Q4 Earnings and Revenues Beat, Operating Margin Down
PAHC's impressive fourth-quarter fiscal 2024 results can be attributed to the Animal Health segment's robust performance.
Phibro Q4 Earnings and Revenues Beat, Operating Margin Down
PAHC's impressive fourth-quarter fiscal 2024 results can be attributed to the Animal Health segment's robust performance.
08/28 20:00 EST - zacks.com
Here's What Key Metrics Tell Us About Phibro (PAHC) Q4 Earnings
While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Phibro (PAHC) Q4 Earnings
While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
08/28 19:20 EST - zacks.com
Phibro Animal Health (PAHC) Beats Q4 Earnings and Revenue Estimates
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.38 per share a year ago.
Phibro Animal Health (PAHC) Beats Q4 Earnings and Revenue Estimates
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.38 per share a year ago.
08/28 16:53 EST - businesswire.com
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2024 and provided its financial guidance for the year ending June 30, 2025. Highlights for the three months ended June 30, 2024 (compared to the three months ended June 30, 2023) Net sales of $273.2 million, an increase of $18.1 million, or 7% Net income of $0.8 million, a decrease of $10.7 million Dil.
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2024 and provided its financial guidance for the year ending June 30, 2025. Highlights for the three months ended June 30, 2024 (compared to the three months ended June 30, 2023) Net sales of $273.2 million, an increase of $18.1 million, or 7% Net income of $0.8 million, a decrease of $10.7 million Dil.
08/26 06:31 EST - zacks.com
Phibro (PAHC) Stock Jumps 10.2%: Will It Continue to Soar?
Phibro (PAHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Phibro (PAHC) Stock Jumps 10.2%: Will It Continue to Soar?
Phibro (PAHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
08/23 10:40 EST - zacks.com
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
08/23 10:21 EST - zacks.com
Countdown to Phibro (PAHC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Phibro (PAHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
Countdown to Phibro (PAHC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Phibro (PAHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
08/21 11:06 EST - zacks.com
Phibro Animal Health (PAHC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Phibro (PAHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Phibro Animal Health (PAHC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Phibro (PAHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
08/05 13:10 EST - zacks.com
Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?
Phibro (PAHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?
Phibro (PAHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
08/05 08:56 EST - zacks.com
Is Phibro (PAHC) Stock Worth Retaining in Your Portfolio Now?
Phibro's (PAHC) Animal Health business, supported by the flourishing Vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.
Is Phibro (PAHC) Stock Worth Retaining in Your Portfolio Now?
Phibro's (PAHC) Animal Health business, supported by the flourishing Vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.